BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 874.8M | 450.7M | 331.4M | 270.8M | 157.2M | 17.8M | 48.8M | 20.7M | 25.2M | 26.4M | 48.3M | 13.6M | 17.3M | 26.3M | 19.6M | 62.4M | 74.6M |
| Gross Profit | 855.8M | 438.4M | 326.9M | 264.4M | 149.9M | 16.3M | 45.1M | — | 24.0M | 24.1M | 46.9M | 13.6M | — | — | — | 62.3M | 70.0M |
| Profitability | |||||||||||||||||
| Operating Income | 341.0M | -2.5M | -103.7M | -148.4M | -177.7M | -174.8M | -99.5M | -94.2M | -57.4M | -48.6M | -39.4M | -45.8M | -30.7M | -33.9M | -49.6M | -34.4M | -13.7M |
| EBITDA | 342.4M | -1.3M | -102.1M | -147.0M | -176.9M | -174.0M | -98.7M | -93.5M | -56.7M | -48.1M | -39.3M | -45.6M | -30.4M | -33.3M | -48.7M | -32.1M | — |
| Net Income | 263.9M | -88.9M | -226.5M | -247.1M | -184.1M | -182.8M | -108.9M | -101.3M | -65.8M | -55.1M | -43.0M | -45.2M | -30.1M | -39.1M | -56.9M | -33.9M | -13.5M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 219M | 207M | 192M | 186M | 179M | 167M | 116M | 103M | 84M | 74M | 73M | 67M | 55M | 51M | 46M | 45M | — |
BioCryst Pharmaceuticals Inc. Income Statement — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BCRX's income statement history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.